Table 2.
Exacerbation Distributions and Annualized Rates for the Analytic Cohort Based on Longitudinal Follow-up Surveys, by GOLD Stage
|
PRISm |
GOLD 0 |
GOLD 1 |
GOLD 2 |
GOLD 3 |
GOLD 4 |
---|---|---|---|---|---|---|
n | 282 | 1,111 | 230 | 544 | 339 | 125 |
All exacerbations | ||||||
≥1 event during follow-up, % | 30.5 | 21.5 | 27.4 | 46.5 | 70.2 | 69.6 |
Percentage with average of 1 or more per year | 12.8 | 4.1 | 7.0 | 12.5 | 28.6 | 35.2 |
Percentage with average of 2 or more per year | 3.9 | 1.2 | 1.3 | 4.4 | 10.0 | 12.0 |
Mean rate, per year | 0.30 | 0.13 | 0.18 | 0.36 | 0.72 | 0.89 |
Severe exacerbations | ||||||
≥1 event during follow-up, % | 13.5 | 8.1 | 10.0 | 24.1 | 42.2 | 47.2 |
Percentage with average of 1 or more per year | 4.6 | 0.9 | 0.4 | 2.8 | 5.6 | 11.2 |
Percentage with average of 2 or more per year | 1.1 | 0.4 | 0.0 | 0.4 | 0.9 | 1.6 |
Mean rate, per year | 0.10 | 0.04 | 0.04 | 0.11 | 0.20 | 0.31 |
Definition of abbreviations: GOLD = Global Initiative for Chronic Obstructive Lung Disease; PRISm = preserved ratio impaired spirometry.
Longitudinal follow-up surveys were available on 1,937 of 2,000 completers and 694 of 861 late subjects in the analytic cohort, combined above.